Led · Seed · Jul 2026

EverSettled provides a platform combining AI and human specialists to guide executors through estate settlement, including a 24/7 AI assistant named Sage and a personalized interactive checklist. Launched four months before the funding, the company says it has helped thousands of families across the U.S. and is available in all 50 states. The product can locate bank accounts and policies, cancel subscriptions, negotiate debts, organize documents, and allow multiple family members to collaborate. EverSettled charges about $1,499 billed to the estate, positioning its offering between self-serve software and high-end concierge services. Founded by Arum Kempster and Jacob Effenberger, the team built the product after interviewing more than 170 families and estate professionals and observing probate court processes. With the new funding, the company plans to expand hiring and broaden services to handle more complex estates.

Participated · Series C · Jul 2026

Together AI is an AI neocloud founded in 2022 that offers AI-specific infrastructure and tooling to support deployment and usage of open-source models. The company says its platform has driven a tripling of open-source model usage across the industry and reports thousands of paying customers, including Cursor, Cognition, and Decagon. Financially, Together AI reported annual bookings of over $1.15 billion as of its last quarter. Its team includes co-founders Vipul Ved Prakash, Percy Liang, and Ce Zhang. Together AI has raised multiple rounds to date, including a $102.5 million Series A in 2023 and a $305 million Series B about 16 months before this Series C. The company operates amid strong VC interest in neocloud providers and infrastructure for AI model deployment.

Participated · Series A · Jun 2026

Prosper AI operates an AI platform that automates the full patient journey — answering patient calls, scheduling appointments directly in electronic health records, verifying insurance benefits, automating patient billing, and contacting insurers when needed. The company reports it helps providers lower administrative costs by over 40% and gives patients visibility into coverage and financial responsibility before care. Since its last funding announcement six months ago, Prosper AI grew revenue fivefold, added more than 40 healthcare organizations as customers, and expanded across more than 150,000 healthcare providers. The platform now powers more than $1.3 billion in patient care. Prosper AI was founded in Spain and has seen rapid adoption from provider groups, health systems, and healthcare technology companies. The company plans to use new capital to grow engineering and customer teams, deepen EHR integrations, and accelerate broader adoption.

Participated · Series C · Jun 2026

Bland builds in-house voice AI models optimized for long, non-linear, high-stakes conversations and deploys them as production-grade agents across phone, SMS, and chat. Its models are designed to handle long interactions—typical calls last 30 to 45 minutes—and to track context, adapt in real time, and carry interactions to resolution. Bland serves regulated industries including healthcare and financial services and handled more than 3.5 million calls per week, 175 million AI phone calls in the prior year, and counts 250+ enterprise customers and hundreds of thousands of self-service users. The company emphasizes building models purpose-built for voice to address latency, interruption, ambiguity, and continuity as core system requirements. Following the Series C, Bland plans to expand research, grow its engineering team, and continue scaling its platform across industries where conversations are central to operations.

Led · Seed · Jun 2026

Radical Numerics develops large-scale biological AI to read and write whole genomes and to detect AI-generated pathogens. The founding team previously trained Evo and Evo 2, described as 40B-parameter models trained on trillions of DNA tokens and released as fully open source. The company previewed Omnii, which it says surpasses Evo 2 and is being further trained with additional modalities. Radical Numerics positions itself with a dual mandate: advancing biological design for human health and building technologies for biosecurity. It has announced partnerships to apply Omnii for early cancer detection with a diagnostics company and to pilot pathogen detection with a U.S. national lab. The company raised a $50 million Seed round to scale its models, grow the team, and accelerate its mission.